General
Preferred name
METHIONINE
Synonyms
L-Methionin ()
L(-)-Methionin ()
L-methionine ()
Methionine C-11 ()
METHIONINE C 11 ()
NSC-22946 ()
L-Methionine ()
Racemethionine ()
Methionine ()
L-Methionine-d3 ()
P&D ID
PD010211
CAS
63-68-3
26062-47-5
3654-96-4
24425-78-3
33807-07-7
58576-49-1
13010-53-2
Tags
drug candidate
natural product
drug
available
Approved by
FDA
Drug Status
nutraceutical
investigational
approved
Drug indication
Amino Acid,Radioactive Agent
Discovery agent
Radioactive Agent
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
21
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
68
Properties
(calculated by RDKit )
Molecular Weight
149.05
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
0
Aromatic Ring Count
0
cLogP
0.15
TPSA
63.32
Fraction CSP3
0.8
Chiral centers
1.0
Largest ring
0.0
QED
0.6
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Metabolism
Metabolic Enzyme/Protease
Target
Endogenous Metabolite
BHMT, BHMT2, METAP2, MTR, MTRR
Disease Area
pulmonary, allergy, neurology/psychiatry
Indication
asthma, allergic rhinitis, depression, Parkinson's Disease, schizophrenia
MOA
voltage-gated calcium channel ligand
Source data
